2m 2m 2m 2m 2m 2m 2m
REPLIMUNE GRP (REPL)
NASDAQ
$9.90+$1.03 (+11.61%)
Price as of Jun 03, 2026 7:18 PM EDT- $717.6MMarket Cap
- -7.89%1-Year Change
- BiotechnologyIndustry
REPLIMUNE GRP (REPL)
$9.90+$1.03 (+11.61%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -189.4M +8.28% | -175.0M +38.28% | -126.5M +59.06% | -79.5M +40.16% | |
Depreciation and Amortization Expense | 3.5M +31.90% | 2.7M +8.50% | 2.4M +13.97% | 2.1M +25.48% | |
Total Operating Expenses | 261.6M +11.44% | 234.8M +32.58% | 177.1M +49.67% | 118.3M +47.98% | |
Operating Profit | -261.6M +11.44% | -234.8M +32.58% | -177.1M +49.67% | -118.3M +47.98% | |
Interest Income | 21.1M -9.57% | 23.4M +133.42% | 10.0M +2,465.64% | 390,000 -57.42% | |
Interest Expense | -5.8M +28.42% | -4.5M +129.09% | -2.0M N/A | 0 +100.00% | |
Interest Income and Expense and Net | 15.3M -18.63% | 18.9M +134.48% | 8.0M +1,962.31% | 390,000 +297.96% | |
Total Nonoperating Income and Expense | 14.8M -23.67% | 19.4M +528.63% | 3.1M +1,009.35% | 278,000 +130.38% | |
Income before Taxes | -246.8M +14.60% | -215.4M +23.79% | -174.0M +47.41% | -118.0M +45.96% | |
Income Taxes | 468,000 +14.71% | 408,000 +41.67% | 288,000 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -247.3M +14.60% | -215.8M +23.82% | -174.3M +47.65% | -118.0M +45.96% | |
Net Income from Continuing Operations Applicable to Common | -247.3M +14.60% | -215.8M +23.82% | -174.3M +47.65% | -118.0M +45.96% | |
Basic EPS and Net Income | -3.07 -5.25% | -3.24 +8.36% | -2.99 +32.30% | -2.26 +29.14% | |
Diluted EPS and Net Income | -3.07 -5.25% | -3.24 +8.36% | -2.99 +32.30% | -2.26 +29.14% | |
Basic Weighted Average Shares | 80.6M +21.02% | 66.6M +14.36% | 58.2M +11.49% | 52.2M +12.89% | |
Diluted Weighted Average Shares | 80.6M +21.02% | 66.6M +14.36% | 58.2M +11.49% | 52.2M +12.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 111.1M +49.24% | 74.5M -49.21% | 146.6M +38.36% | 105.9M -41.95% | |
Short-Term Investments | 372.7M +7.65% | 346.2M -20.74% | 436.8M +50.77% | 289.7M -1.39% | |
Cash and Cash Equivalents and Short-Term Investments | 483.8M +15.01% | 420.7M -27.89% | 583.4M +47.45% | 395.7M -16.93% | |
Total Current Assets | 495.9M +14.35% | 433.7M -26.82% | 592.6M +46.69% | 404.0M -16.49% | |
Accumulated Depreciation | 13.4M +35.38% | 9.9M +36.66% | 7.2M +51.03% | 4.8M +81.08% | |
Property and Plant and Equipment and Net | 13.7M +31.06% | 10.5M +40.17% | 7.5M -5.72% | 7.9M +6.60% | |
Total Long-Term Assets | 1.2M -88.55% | 10.5M +40.17% | 7.5M -5.72% | 7.9M +6.60% | |
Total Assets | 551.3M +13.04% | 487.7M -24.57% | 646.6M +40.20% | 461.2M -15.08% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 10.0M 0.00% | |
Total Current Liabilities | 62.4M +54.22% | 40.4M +19.55% | 33.8M +62.96% | 20.8M +42.68% | |
Total Long-Term Debt | 46.4M +3.50% | 44.8M +56.41% | 28.6M N/A | N/A N/A | |
Total Long-Term Liabilities | 941,000 +19.72% | 786,000 +66.53% | 472,000 -90.17% | 4.8M -67.73% | |
Total Liabilities | 135.5M +19.67% | 113.2M +24.00% | 91.3M +82.73% | 50.0M +12.61% | |
Retained Earnings | -948.6M +35.26% | -701.3M +44.45% | -485.5M +56.00% | -311.2M +61.11% | |
Total Stockholders Equity | 415.8M +11.04% | 374.5M -32.56% | 555.3M +35.03% | 411.2M -17.54% | |
Total Shares Outstanding | 77.1M +25.51% | 61.4M +8.36% | 56.7M +19.73% | 47.3M +1.66% | |
Cash Flow | |||||
Cash from Operating Activities | -192.3M +3.66% | -185.5M +44.84% | -128.1M +55.82% | -82.2M +33.87% | |
Capital Expenditures | 6.7M +18.10% | 5.7M +149.43% | 2.3M -2.83% | 2.3M -2.34% | |
Cash from Investing Activities | -23.8M -124.48% | 97.2M +168.21% | -142.5M +7,790.48% | -1.8M -99.04% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 252.4M +1,450.06% | 16.3M -94.77% | 311.3M +4,618.14% | 6.6M -98.23% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -47.60% +25.11% | -38.05% +20.92% | -31.47% +33.86% | -23.51% +12.95% | |
Return on Equity | -62.58% +34.82% | -46.42% +28.71% | -36.06% +39.01% | -25.94% +9.46% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 7.95 -25.85% | 10.72 -38.79% | 17.52 -9.99% | 19.46 -41.47% | |
Cash Ratio | 1.78 -3.23% | 1.84 -57.51% | 4.33 -15.10% | 5.10 -59.32% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow